The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical, healthcare, and specialist food industries where process monitoring of viable particles is necessary.
Cherwell introduced new models to its ImpactAir range of microbial air monitors distributed from Pinpoint Scientific.
The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical industry as well as other industries (e.g., healthcare, specialist food industries) where process monitoring of viable particles is necessary. Both ranges are equipped with a chamber for a 90-mm petri dish and use a slit-to-agar method that ensures particles, including microbes, impact the petri dish’s agar surface. As the dish rotates under the inlet, air is impacted onto an area of agar, reducing twin impingement risk and microbe desiccation for a high biological and physical efficiency.
Additionally, each range includes an ISO-90 Monitoring Head that contains all the controls needed to rotate the agar plate during the monitoring phase.
Individually, the ISO-90 range consists of:
The ImpactAir-90 range includes:
“We are really excited by the opportunities that the new range of air monitors from Pinpoint offer,” said Andy Whittard, managing director at Cherwell, in an April 21, 2021 press release. “The compact, 90-mm Petri version slit-to-agar range can help users address the challenges presented by the new Annex 1 and the focus on continuous monitoring. The various options also provide users with differing solutions for challenges within their facilities.”
Source: Cherwell
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.